(CDZI) Cadiz - Overview
Stock: Water, Storage, Filtration, Alfalfa
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 69.0% |
| Relative Tail Risk | -3.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -28.59 |
| Character TTM | |
|---|---|
| Beta | 1.262 |
| Beta Downside | 1.588 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.97% |
| CAGR/Max DD | 0.05 |
Description: CDZI Cadiz January 02, 2026
Cadiz Inc. (NASDAQ: CDZI) is a U.S.-based water-solutions provider that operates two segments: (1) Land and Water Resources, delivering water supply, storage, and conveyance services; and (2) Water Filtration Technology, offering treatment for impaired or contaminated groundwater. The company also cultivates grain crops such as alfalfa and serves a mix of public utilities, government agencies, and commercial customers. Founded in 1983 and headquartered in Los Angeles, California, Cadiz positions itself as an integrated water-resource manager.
Key market metrics (as of the most recent quarter) include a market-cap of roughly $350 million and annual revenue of about $45 million, reflecting a 12 % year-over-year growth driven primarily by contracts tied to drought-mitigation projects in the Southwest. The sector’s growth catalyst is the U.S. federal water-infrastructure bill, which is expected to inject over $50 billion into water-storage and treatment projects through 2030-benefiting firms with proven conveyance and filtration capabilities. Cadiz’s flagship “WaterBank” project aims to store up to 500 billion gallons of water, a scale that could capture a meaningful share of the projected $4 billion annual spend on large-scale water-storage assets in the region.
For a deeper dive into how Cadiz’s assets compare to peer benchmarks and the broader water-utility outlook, you might explore the ValueRay platform’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -33.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.19 > 0.02 and ΔFCF/TA 1.30 > 1.0 |
| NWC/Revenue: 14.94% < 20% (prev 57.02%; Δ -42.08% < -1%) |
| CFO/TA -0.14 > 3% & CFO -18.2m > Net Income -33.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.1m) vs 12m ago 20.74% < -2% |
| Gross Margin: 32.47% > 18% (prev -0.14%; Δ 3261 % > 0.5%) |
| Asset Turnover: 13.28% > 50% (prev 4.92%; Δ 8.36% > 0%) |
| Interest Coverage Ratio: -2.81 > 6 (EBITDA TTM -22.8m / Interest Expense TTM 8.67m) |
Altman Z'' -15.00
| A: 0.02 (Total Current Assets 11.7m - Total Current Liabilities 9.33m) / Total Assets 128.0m |
| B: -5.33 (Retained Earnings -682.4m / Total Assets 128.0m) |
| C: -0.20 (EBIT TTM -24.3m / Avg Total Assets 120.3m) |
| D: -6.80 (Book Value of Equity -681.6m / Total Liabilities 100.3m) |
| Altman-Z'' Score: -25.75 = D |
Beneish M -2.03
| DSRI: 0.39 (Receivables 3.65m/3.24m, Revenue 16.0m/5.54m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.45 (AQ_t 0.15 / AQ_t-1 0.10) |
| SGI: 2.88 (Revenue 16.0m / 5.54m) |
| TATA: -0.12 (NI -33.0m - CFO -18.2m) / TA 128.0m) |
| Beneish M-Score: -2.03 (Cap -4..+1) = BB |
What is the price of CDZI shares?
Over the past week, the price has changed by -13.04%, over one month by -17.78%, over three months by -3.71% and over the past year by -9.32%.
Is CDZI a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CDZI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.5 | 167.7% |
| Analysts Target Price | 12.5 | 167.7% |
| ValueRay Target Price | 4.6 | -1.7% |
CDZI Fundamental Data Overview February 03, 2026
P/S = 29.6348
P/B = 17.053
Revenue TTM = 16.0m USD
EBIT TTM = -24.3m USD
EBITDA TTM = -22.8m USD
Long Term Debt = 59.8m USD (from longTermDebt, last quarter)
Short Term Debt = 455.0k USD (from shortTermDebt, last quarter)
Debt = 30.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.5m USD (from netDebt column, last quarter)
Enterprise Value = 500.0m USD (473.5m + Debt 30.9m - CCE 4.43m)
Interest Coverage Ratio = -2.81 (Ebit TTM -24.3m / Interest Expense TTM 8.67m)
EV/FCF = -20.09x (Enterprise Value 500.0m / FCF TTM -24.9m)
FCF Yield = -4.98% (FCF TTM -24.9m / Enterprise Value 500.0m)
FCF Margin = -155.7% (FCF TTM -24.9m / Revenue TTM 16.0m)
Net Margin = -206.6% (Net Income TTM -33.0m / Revenue TTM 16.0m)
Gross Margin = 32.47% ((Revenue TTM 16.0m - Cost of Revenue TTM 10.8m) / Revenue TTM)
Gross Margin QoQ = 27.33% (prev 35.41%)
Tobins Q-Ratio = 3.91 (Enterprise Value 500.0m / Total Assets 128.0m)
Interest Expense / Debt = 7.04% (Interest Expense 2.17m / Debt 30.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -19.2m (EBIT -24.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.26 (Total Current Assets 11.7m / Total Current Liabilities 9.33m)
Debt / Equity = 1.11 (Debt 30.9m / totalStockholderEquity, last quarter 27.7m)
Debt / EBITDA = -1.16 (negative EBITDA) (Net Debt 26.5m / EBITDA -22.8m)
Debt / FCF = -1.06 (negative FCF - burning cash) (Net Debt 26.5m / FCF TTM -24.9m)
Total Stockholder Equity = 35.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -27.45% (Net Income -33.0m / Total Assets 128.0m)
RoE = -93.46% (Net Income TTM -33.0m / Total Stockholder Equity 35.3m)
RoCE = -25.57% (EBIT -24.3m / Capital Employed (Equity 35.3m + L.T.Debt 59.8m))
RoIC = -20.52% (negative operating profit) (NOPAT -19.2m / Invested Capital 93.7m)
WACC = 10.25% (E(473.5m)/V(504.4m) * Re(10.56%) + D(30.9m)/V(504.4m) * Rd(7.04%) * (1-Tc(0.21)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.95%
Fair Price DCF = unknown (Cash Flow -24.9m)
EPS Correlation: 55.61 | EPS CAGR: 51.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.42 | Revenue CAGR: 145.9% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.10 | Chg30d=+0.010 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.25 | Chg30d=+0.060 | Revisions Net=-1 | Growth EPS=-204.2% | Growth Revenue=+32.9%